| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1. The synthesis, distribution, storage, and subsequent metabolism of 5-hydroxytryptamine (5-HT) produced in mice from the administration of its radioactive precursor, 5-hydroxytryptophan, has been investigated to form the basis for a similar study to be conducted by radioautography.
2. Intravenous injection of the radioactive material was found to be essential for significant uptake of radioactivity by tissue. The duration of the period during which radioactive material was available for uptake by the tissue was 2 hr.
3. The relative distribution of radioactivity in individual organs was studied and the radioactive compounds present in each were identified and quantitatively assayed. No unrelated routes of metabolism of the labelled material were found and radioautographic results may be interpreted in terms of the metabolic picture which emerged.
4. Radioactive 5-HT was bound in tissues in preference to both its precursor, and metabolite, 5-hydroxytryptamine-O-glucuronide, and the radioactive 5-HT produced in vivo after the injection of labelled 5-hydroxytryptophan probably entered and labelled the endogenous 5-HT pool.
5. Fixatives prepared with buffer solutions made hypertonic by the addition of sucrose could rapidly and effectively halt the movement of radioactive 5-HT out of tissues and prevent its subsequent extraction during histological processing.
6. It is concluded that localization of sites concerned with 5-HT metabolism by means of radioautography is feasible and the 5-HT so localized will probably reflect the physiological compartmentalization of the amine.
This article has been cited by other articles:
|
|
 |
|
  L. N. Squires, J. A. Jakubowski, J. N. Stuart, S. S. Rubakhin, N. G. Hatcher, W.-S. Kim, K. Chen, J. C. Shih, I. Seif, and J. V. Sweedler Serotonin Catabolism and the Formation and Fate of 5-Hydroxyindole Thiazolidine Carboxylic Acid J. Biol. Chem., May 12, 2006; 281(19): 13463 - 13470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F De Ponti Pharmacology of serotonin: what a clinician should know Gut, October 1, 2004; 53(10): 1520 - 1535. [Full Text] [PDF]
|
|
|
|
 |
|
 M.-T. Liu, S. Rayport, Y. Jiang, D. L. Murphy, and M. D. Gershon Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter Am J Physiol Gastrointest Liver Physiol, December 1, 2002; 283(6): G1398 - G1411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Chen, Z. Li, H. Pan, D. L. Murphy, H. Tamir, H. Koepsell, and M. D. Gershon Maintenance of Serotonin in the Intestinal Mucosa and Ganglia of Mice that Lack the High-Affinity Serotonin Transporter: Abnormal Intestinal Motility and the Expression of Cation Transporters J. Neurosci., August 15, 2001; 21(16): 6348 - 6361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-X. Chen, H. Pan, T. P. Rothman, P. R. Wade, and M. D. Gershon Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception Am J Physiol Gastrointest Liver Physiol, September 1, 1998; 275(3): G433 - G448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Blaugrund, T. Pham, V. Tennyson, L Lo, L Sommer, D. Anderson, and M. Gershon Distinct subpopulations of enteric neuronal progenitors defined by time of development, sympathoadrenal lineage markers and Mash-1-dependence Development, January 1, 1996; 122(1): 309 - 320. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
